Connect your AI

Globus Medical GMED Amortized cost of available-for-sale debt securities, current

Amortized cost of available-for-sale debt securities, current at other companies

BK

BKBK

$107.65B+9.8%

Ally FinancialALLY

$4.6B—

Bank of AmericaBAC

$903.7B-4.1%

BK

BKBK

$150.2B+9.9%

Two Harbors Investment CorporationTWO

$1.15B-15.9%

PopularBPOP

——

Other financials

Income statement

Revenue$759.9M+27.0%

Gross profit$525.8M+30.6%

Operating income$150.4M+55.0%

Net income$124.3M+64.7%

EPS (diluted)$0.90+66.7%

Balance sheet

Cash & equivalents$561.0M+21.6%

Total debt$116.3M+25.0%

Total equity$4.7B+15.8%

Total assets$5.4B+15.5%

Cash flow

Operating cash flow$202.4M+14.1%

CapEx$39.6M+9.7%

Free cash flow$162.7M+15.3%

Valuation

Market cap$10.76B+15.7%

Enterprise value$10.31B+15.6%

P/E18.3×-31.7×

P/S3.5×-0.2×

Profitability

Gross margin67.9%+7.3pp

Operating margin17.2%+7.0pp

Net margin18.9%+11.5pp

FCF margin19.7%-1.1pp

Returns & leverage

Return on equity13.3%+8.7pp

Debt / equity0×0.0×

Current ratio4.6×+0.1×

Where this comes from

Reported directly by Globus Medical in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent.

The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Globus Medical's amortized cost of available-for-sale debt securities, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Globus Medical's amortized cost of available-for-sale debt securities, current?: Globus Medical (GMED) reported amortized cost of available-for-sale debt securities, current of $68.94M in Q1 2026.
What is the long-term trend for Globus Medical's amortized cost of available-for-sale debt securities, current?: Over 4 years (2021 to 2025), Globus Medical's amortized cost of available-for-sale debt securities, current has grown at a -40.6% compound annual growth rate (CAGR), from $249.9M to $31.07M.